CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Illumina and Natera announced they have entered into a three-year agreement whereby Illumina will supply Natera with the HiSeq 2500 sequencing system and associated consumables for performing Natera’s noninvasive prenatal test (NIPT) Panorama.
“We are pleased to be selected again as Natera’s next-generation sequencing system provider, to support the growth of its Panorama test,” said Illumina’s senior vice president of corporate and venture development, Nick Naclerio. “Illumina’s goal is to enable the rapid growth of NIPT and the broader reproductive health market with technology, products, and ultimately FDA-approved in vitro diagnostic systems.”
Illumina, 858-882-6822
Natera, 650-249-9090